Back

Application of anticoagulants in the perioperative period of pci for patients with a history of atrial fibrillation and NSTEMI: a real-world, large multicenter retrospective clinical study

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Arrhythmias and acute coronary syndromes: focus on atrial fibrillation and cardiac arrest Non-ST-Elevation Myocardial Infarction (NSTEMI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Kang-Yin Chen

2nd Hospital of Tianjin Medical University, Tianjin (China)

6 More presentations in this session

Presentation thumbnail
Antithrombotic therapy in patients with atrial fibrillation after myocardial infarction and percutaneous coronary intervention.
Mr M. Skibniewski (Linkoping, SE)
Abstract Slides Video
Presentation thumbnail
Embolic myocardial infarction. Clinical characteristics, etiology, and prognosis
Doctor M. Calvo-Barcelo (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Impact of the complexity of percutaneous coronary intervention on clinical outcomes in patients with atrial fibrillation: a real-world study
Doctor Y. Wang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Sudden cardiac death in acute coronary occlusion: potential roles of sino-atrial nodal artery and conus artery
Doctor J. Bhar-Amato (Wellington, NZ)
Abstract Slides Video
Presentation thumbnail
Novel protein-based biomarkers of out-of-hospital sudden cardiac death after myocardial infarction
Professor M. Zhang (Harbin, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias and acute coronary syndromes: focus on atrial fibrillation and cardiac arrest

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin
thumbnail
Congress Presentation
Temporal trends of prescription rates, dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation
thumbnail
Congress Presentation
Optimal anticoagulant strategy for periprocedural management of atrial fibrillation ablation: a systematic review and network meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources